Beta-blocker therapy after myocardial infarction with preserved LVEF (≥50%): a systematic review and Bayesian meta-analysis with time-to-event reconstruction
β-blockers were not associated with a clear reduction in all-cause mortality or other outcomes, as credible intervals included the null. Large, randomized trials are needed to define their long-term role in this population.
Authors
- Nihar Jena (ORCID: https://orcid.org/0000-0002-7702-9034)
- Jennifer Gerdes
- George Sokos (ORCID: https://orcid.org/0000-0001-7421-0148)
- Yousif Hameed Kurmasha
- Belal Mohamed Hamed (ORCID: https://orcid.org/0009-0003-8049-5209)
- Yasar Sattar
- Ali Saad Al-Shammari
- M. Rafiqul Islam
- Bara M. Hammadeh
- Ramesh Daggubati
- Haider Altaii
- Nabeel Ibraheem Khaleel
- Marwan Refaat
Institutions
- University of Baghdad (IQ)
- Al-Azhar University (EG)
- Aultman Hospital (US)
- Al-Balqa Applied University (JO)
- Ark Medical Center (US)
- American University of Beirut Medical Center (LB)
- Shaheed Suhrawardy Medical College (BD)
- University of Kufa (IQ)
Publication Details
- Journal
- American Heart Journal Plus Cardiology Research and Practice
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1016/j.ahjo.2025.100706
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00